Cinchona genus is the source of a variety of alkaloids, the most familiar of which is quinine, an antipyretic (antifever) agent especially useful in treating malaria. Cinchona alkaloids include: They find use in organic chemistry as organocatalysts in asymmetric synthesis. Alongside the alkaloids, many cinchona barks contain cinchotannic acid, a particular tannin, which by oxidation rapidly yields a dark-coloured phlobaphene called red cinchonic, cinchono-fulvic acid or cinchona red. In 1934, efforts to make malaria drugs cheap and effective for use across countries led to the development of a standard called "totaquina" proposed by the Malaria Commission of the League of Nations.
Cinchona people. Italian sources spelt Quina as Cina which was a source of confusion with "Smilax" from China. Haggis argued that Qina and Jesuit's bark actually referred to "Myroxylon peruiferum" or Peruvian balsam and that this was an item of importance in Spanish trade in the 1500s. Over time, the bark of the "Myroxylon" was adulterated with the similar looking bark of what we now know as "Cinchona". Gradually the adulterant became the main product that was the key therapeutic ingredient used in malarial therapy. The bark was included as "Cortex Peruanus" in the London Pharmacopoeia in 1677. The "fever tree"